Commonwealth Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696K Sell
1,922
-54
-3% -$18.5K 0.09% 127
2026
Q1
$695K Buy
1,976
+30
+2% +$10.7K 0.11% 104
2025
Q4
$637K Sell
1,946
-55
-3% -$17.4K 0.11% 106
2025
Q3
$565K Buy
2,001
+8
+0.4% +$2.32K 0.1% 108
2025
Q2
$556K Buy
1,993
+18
+0.9% +$5.1K 0.11% 106
2025
Q1
$615K Buy
1,975
+116
+6% +$34.3K 0.13% 100
2024
Q4
$484K Buy
1,859
+165
+10% +$49K 0.09% 105
2024
Q3
$543K Sell
1,694
-45
-3% -$14.7K 0.11% 99
2024
Q2
$542K Sell
1,739
-15
-0.9% -$4.41K 0.11% 98
2024
Q1
$505K Hold
1,754
0.12% 88
2023
Q4
$505K Sell
1,754
-57
-3% -$15.5K 0.12% 88
2023
Q3
$487K Buy
+1,811
New +$452K 0.14% 98
2017
Q1
$150K Hold
926
0.16% 63
2016
Q4
$143K Sell
926
-1,931
-68% -$291K 0.14% 64
2016
Q3
$477K Buy
2,857
+2,757
+2,757% +$466K 0.45% 25
2016
Q2
$15K Hold
100
0.02% 149
2016
Q1
$15K Hold
100
0.02% 130
2015
Q4
$16K Hold
100
0.05% 125
2015
Q3
$14K Hold
100
0.02% 135
2015
Q2
$15K Hold
100
0.02% 149
2015
Q1
$16K Hold
100
0.01% 149
2014
Q4
$16K Buy
+100
New +$15.6K 0.01% 140

Other funds holding AMGN

Commonwealth Financial Services's AMGN Position: Q2 2026 in Review

Commonwealth Financial Services reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $18.5K and leaving 1,922 shares worth $696K. The position accounts for 0.09% of the portfolio, ranked #127.

Commonwealth Financial Services first reported a position in AMGN in Q4 2014 and has held it in 22 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Commonwealth Financial Services held 1,922 shares of Amgen worth $696K as of Q2 2026.
  • Commonwealth Financial Services sold 54 Amgen shares in Q2 2026, an estimated $18.5K.
  • Amgen made up 0.09% of Commonwealth Financial Services's portfolio in Q2 2026, its #127 holding.
  • Commonwealth Financial Services first reported a position in Amgen in Q4 2014 and has held it in 22 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Commonwealth Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.